Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Thoratec Reports Third Quarter Fiscal 2011 Results
Date:11/1/2011
ure periods with our historical operating results, and assist in analyzing future trends.
Non-GAAP net income consists of GAAP net income, excluding, as applicable, the tax effected impact of share-based compensation expense, amortization of purchased intangibles, expenses associated with the accounting for convertible debt instruments that may be settled in cash upon conversion, including partial settlements in accordance with Financial Accounting Standards Board ("FASB") issued Accounting Standards Codification ("ASC") 470-20, Debt, Levitronix Medical transaction costs, and fair market value inventory adjustments related to the Levitronix Medical acquisition.
Non-GAAP net income per diluted share is defined as non-GAAP net income divided by the weighted average number of shares on a fully-diluted basis.
Non-GAAP shares used to compute diluted net income per share consists of GAAP shares used to compute diluted net income per share adjusted for any inclusions made in conjunction with dilutive impact of Thoratec's convertible debt instruments and any exclusions made in conjunction with the application of the two-class method for calculating net income per share.
Non-GAAP gross profit and gross margin consist of GAAP gross profit and gross margin excluding share-based compensation expense and accounting for fair market value inventory adjustments related to the Levitronix Medical acquisition.
Non-GAAP operating expenses consist of GAAP operating expenses excluding share-based compensation expense, amortization of purchased intangibles, and Levitronix Medical transaction costs.
Non-GAAP other income and expense consists of GAAP other income and expenses excluding expenses related to the accounting for convertible debt instruments that may be settled in cash upon conversion, including partial settlements, in accordance with ASC 470-20, Debt.
Non-GAAP
'/>"/>
| SOURCE Thoratec Corporation Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
(Date:5/20/2013)... CARLSBAD, Calif. , May 20, 2013 ... today announced that its Applied Biosystems™ 3500 Dx and ... Federal Commission for Protection against Health Risks in ... marks a major extension of Life Technologies, capabilities to ... America with Sanger -based ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... , May 20, 2013 Medicare Part ... are overwhelmingly satisfied, citing lower costs, convenient access ... new survey from Hart Research Associates released today ... than 40% of Part D seniors (9.5 million) ... "Seniors like the lower costs, pharmacy ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2... Stryker Corporation (NYSE: SYK ) reported operating ... as follows: Fourth Quarter Highlights ... (8.8% increase as reported) to $1,995 million Orthopaedic Implant ... as reported) MedSurg Equipment sales increased 15.4% on a ...
... Calif., Jan. 25, 2011 Most people know that ... why they should take them or which vitamins they ... getting the vitamins they need, the Stater Bros. website ... 5-minute personal health survey. The recommendations from this survey ...
Cached Medicine Technology:Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 2Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 3Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 4Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 5Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 6Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 7Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 8Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 9Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 10Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 11Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010 12Stater Bros. Introduces Free Personal Vitamin Recommendation Program 2(Date:5/21/2013)... The National Resident Matching Program NRMP® ... its Board of Directors. Hal B. Jenson, M.D., ... of Medicine, has been named President. Maria C. ... of California San Diego, is the President-Designate, and Glenn ... Medical Center, is the Secretary-Treasurer. Kenneth B. Simons, ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Michigan ... meeting in Lapeer on , June 11th. , Meeting ... Location: Lapeer Regional Medical Center, Conference Room 5 (Lower ... These meetings are designed to assist people with lupus ... one another, and to get a better understanding of ...
(Date:5/21/2013)... The birth control safety advocates at DrugRisk.com ... the contraceptive NuvaRing. A new report shows the number ... increased in recent months*. , DrugRisk was created to ... the latest safety alerts, recalls, studies and legal news. ... side effects and decide if they need legal advice. ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 USA Book ... Transcendent Approach to Peak Performance" won the top honor ... Category. Chosen over a multitude of international titles ... attention and critical acclaim from both mainstream and new ... - mentally, physically and spiritually. , “The ...
(Date:5/20/2013)... Dallas, Texas (PRWEB) May 21, 2013 ... based on product type into two categories - ... AED market is classified into five categories, namely, ... the market is forecast till 2017. Automated external ... lives of sudden cardiac arrest victims. Considering the ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3[0] New Board of Directors Leadership for The Match- National Resident Matching Program®[0] Lupus Support Group Meeting in Lapeer on June 11th[0] DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits[0] Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards[0] North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com
... 9, 2010, describes the discovery of an alternative form of ... sterilize them. Nematodes are among the most abundant, diverse and ... via Symbiosis; Recent Spread of a Drosophila Defensive ... and his colleagues. In a video interview, Jaenike explains the ...
... ... a range of preventable health problems, Sam’s Club is hosting free health screenings in more ... , ... July 8, 2010 -- To help its members and community residents detect a range of ...
... , THURSDAY, July 8 (HealthDay News) -- Scientists report they,ve ... "soldiers" in the immune system that might prevent the AIDS ... researchers, these newly found antibodies connect with and neutralize more ... all major genetic subtypes of the virus. That breadth ...
... provide authors additional time to complete their research, the ... 31 for the Cell Symposia meeting, Influenza: Translating basic ... Marriott Hotel in Washington, DC., Abstracts are invited for ... "Virus biology," "Pandemics, pathogenesis and disease," "Immune response and ...
... . Montreal, July 8, 2010 - A team of ... Cancer (IRIC) of the University of Montreal have identified ... IRIC Principal Investigators Martine Raymond, Alain Verreault and Pierre ... Research Institute of the National Research Council Canada, the ...
... NC Men who have a baseline PSA value of ... up to 11 times more likely to die from prostate ... to Duke University Medical Center researchers. Scientists say ... , supports routine, early prostate-specific antigen (PSA) screening among healthy ...
Cached Medicine News:Health News:Sam's Club Hosts Health Screenings July 10 2Health News:New Anti-HIV Weapons Found in Immune System 2Health News:Cell symposia meeting, Influenza: Translating basic insights, to be held Dec. 2-4, 2010 2Health News:Vitamin B3 as a novel approach to treat fungal infections 2Health News:Baseline PSA predicts risk of death from prostate cancer 2New way to conquer disease-causing nematodes in flies has implications for human diseasesSam's Club Hosts Health Screenings July 10 New Anti-HIV Weapons Found in Immune SystemCell symposia meeting, Influenza: Translating basic insights, to be held Dec. 2-4, 2010Vitamin B3 as a novel approach to treat fungal infectionsBaseline PSA predicts risk of death from prostate cancer
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO 2 Inc....
... The Dual Media Set, different from ... Broth (LB) or other specially prepared medium, ... OVEREXPRESSION BROTH (OB). For cell expansion, E. ... the production of the recombinant protein is ...
...
0.3% Beef extract, 0.5% Peptone, 0.5 % Lactose....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |